Unraveling glymphatic disruption in brain tumors: Insights from perivascular space network analysis
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70441 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Min Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glymphatic System, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Hunan Provincial Innovation Platform and Talent Plan, Key Support Project of the National Natural Science Foundation of China, Key Project of the Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Brain tumors disrupt the glymphatic system—a critical network for cerebrospinal and interstitial fluid circulation via the perivascular spaces (PVS)—yet the extent and underlying mechanisms of this dysfunction remain poorly defined. In a prospective study, 104 brain tumor patients (40 high‐grade gliomas, 26 metastases, and 38 meningiomas) and 30 age‐ and sex‐matched healthy controls underwent advanced MRI assessments to quantify white matter PVS volume fraction (PVSVF‐WM), free water fraction (FW‐WM), and the DTI‐ALPS index. All tumor groups exhibited significantly elevated PVSVF‐WM ( p < .001) and reduced DTI‐ALPS index, indicating PVS dilation and impaired glymphatic function, while FW‐WM showed significant group differences, with the lowest values observed in patients with high‐grade glioma ( p < .001). Tumor volume showed a strong positive correlation with PVSVF‐WM ( ρ = 0.674, p < .001) and a negative correlation with the DTI‐ALPS index ( ρ = −0.482, p < .001). Moreover, in gliomas, Ki67 expression correlated positively with PVSVF‐WM ( ρ = 0.563, p < .001) and negatively with the DTI‐ALPS index ( ρ = −0.482, p = .002), whereas in metastases, p53 expression correlated positively with the DTI‐ALPS index ( ρ = 0.569, p = .002). These findings demonstrate that brain tumors alter the PVS network, leading to glymphatic dysfunction, with the degree of disruption being modulated by tumor burden and molecular characteristics. The innovative MRI‐based metrics used in this study provide valuable insights into tumor‐associated glymphatic alterations and may inform the development of tailored therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Neurosurgery, The Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Radiology, Quality Control Center, Changsha, China.
ORCID-Profile: Jun Liu
Förderung
- Hunan Provincial Innovation Platform and Talent Plan
- Key Support Project of the National Natural Science Foundation of China
- Key Project of the Hunan Provincial Natural Science Foundation
- Hunan Provincial Key Research and Development Program
- Natural Science Foundation of China (NSFC) Youth Fund
- Hunan Provincial Engineering Research Center for Brain Science Imaging
- National Natural Science Foundation of China
Zitieren
APA
Gao, M., Zang, H., Zhao, W., Zhou, Y., & Liu, J. (2026). Unraveling glymphatic disruption in brain tumors: Insights from perivascular space network analysis. International Journal of Cancer. https://doi.org/10.1002/ijc.70441
Vancouver
Gao M, Zang H, Zhao W, Zhou Y, Liu J. Unraveling glymphatic disruption in brain tumors: Insights from perivascular space network analysis. International Journal of Cancer. 2026. doi:10.1002/ijc.70441
BibTeX
@article{Gao2026,
author = {Gao, Min and Zang, Hongjing and Zhao, Wei and Zhou, Yu and Liu, Jun},
title = {Unraveling glymphatic disruption in brain tumors: Insights from perivascular space network analysis},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70441}
}
EUVIMED